| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ALDH18A1 | OXGR1 | ENSCAFP00000012319 | ENSCAFP00000008247 | Delta-1-pyrroline-5-carboxylate synthase; In the C-terminal section; belongs to the gamma-glutamyl phosphate reductase family. | Oxoglutarate receptor 1. | 0.510 |
| CNR1 | CNR2 | ENSCAFP00000004587 | ENSCAFP00000019242 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | 0.932 |
| CNR1 | MTNR1B | ENSCAFP00000004587 | ENSCAFP00000006305 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | 0.508 |
| CNR1 | OXGR1 | ENSCAFP00000004587 | ENSCAFP00000008247 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Oxoglutarate receptor 1. | 0.531 |
| CNR1 | SUCNR1 | ENSCAFP00000004587 | ENSCAFP00000012574 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Succinate receptor 1; Belongs to the G-protein coupled receptor 1 family. | 0.499 |
| CNR2 | CNR1 | ENSCAFP00000019242 | ENSCAFP00000004587 | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.932 |
| CNR2 | MTNR1B | ENSCAFP00000019242 | ENSCAFP00000006305 | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | 0.536 |
| CNR2 | OXGR1 | ENSCAFP00000019242 | ENSCAFP00000008247 | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | Oxoglutarate receptor 1. | 0.525 |
| CNR2 | SUCNR1 | ENSCAFP00000019242 | ENSCAFP00000012574 | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | Succinate receptor 1; Belongs to the G-protein coupled receptor 1 family. | 0.499 |
| LHCGR | OXGR1 | ENSCAFP00000003939 | ENSCAFP00000008247 | Lutropin-choriogonadotropic hormone receptor; Receptor for lutropin-choriogonadotropic hormone. The activity of this receptor is mediated by G proteins which activate adenylate cyclase; Belongs to the G-protein coupled receptor 1 family. FSH/LSH/TSH subfamily. | Oxoglutarate receptor 1. | 0.518 |
| LTB4R2 | OXGR1 | ENSCAFP00000059946 | ENSCAFP00000008247 | Leukotriene B4 receptor 2. | Oxoglutarate receptor 1. | 0.573 |
| MRGPRD | OXGR1 | ENSCAFP00000055052 | ENSCAFP00000008247 | Mas-related G protein-coupled receptor D. | Oxoglutarate receptor 1. | 0.569 |
| MTNR1B | CNR1 | ENSCAFP00000006305 | ENSCAFP00000004587 | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.508 |
| MTNR1B | CNR2 | ENSCAFP00000006305 | ENSCAFP00000019242 | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | Cannabinod receptor; Belongs to the G-protein coupled receptor 1 family. | 0.536 |
| MTNR1B | OXGR1 | ENSCAFP00000006305 | ENSCAFP00000008247 | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | Oxoglutarate receptor 1. | 0.528 |
| MTNR1B | SUCNR1 | ENSCAFP00000006305 | ENSCAFP00000012574 | Melatonin receptor 1B; Belongs to the G-protein coupled receptor 1 family. | Succinate receptor 1; Belongs to the G-protein coupled receptor 1 family. | 0.499 |
| OR2B11 | OXGR1 | ENSCAFP00000015812 | ENSCAFP00000008247 | Olfactory receptor. | Oxoglutarate receptor 1. | 0.523 |
| OR2T1 | OXGR1 | ENSCAFP00000061617 | ENSCAFP00000008247 | Olfactory receptor. | Oxoglutarate receptor 1. | 0.522 |
| OXGR1 | ALDH18A1 | ENSCAFP00000008247 | ENSCAFP00000012319 | Oxoglutarate receptor 1. | Delta-1-pyrroline-5-carboxylate synthase; In the C-terminal section; belongs to the gamma-glutamyl phosphate reductase family. | 0.510 |
| OXGR1 | CNR1 | ENSCAFP00000008247 | ENSCAFP00000004587 | Oxoglutarate receptor 1. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.531 |